Year Founded
2020
Ownership
Private
Employees
~50
Stage
Preclinical
Modalities
Apriori Bio General Information
Drug Pipeline
No pipeline data available
Key Partnerships
CEPI
Apriori Bio Funding
Deal Type | Date | Amount | Status | Stage |
---|
To view Apriori Bio's complete valuation and funding history, request access »
Apriori Bio Investors
Flagship Pioneering ($50 million initial commitment)
Investor Type: Venture Capital
Holding: Minority
CEPI ($1.1 million grant)
Investor Type: Venture Capital
Holding: Minority